Like Synowledge

closed 9/21/2015 via PR Newswire

BioClinica, Inc., acquired Synowledge

synopsis: BioClinica, Inc., a specialty clinical trials services and technology provider, announced that it has acquired Synowledge to expand into the drug safety and regulatory business process outsourcing market. Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies.
buyer parent: JLL Partners
buyer: BioClinica, Inc.
BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. "
target: Synowledge
Synowledge is a specialized drug safety, regulatory affairs and IT services provider that assists and enables small, medium and large life sciences organizations to satisfy their global regulatory requirements.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/20/2021 via BusinessWire

General Atlantic, LLC, acquired CareMetx

synopsis: General Atlantic, a global growth equity firm, has become the majority owner of CareMetx, a leading technology-enabled hub services company improving patient access to specialty medications. The investment from General Atlantic will allow CareMetx to scale its platform, invest in its team, and bring new capabilities to its clients.
buyer: General Atlantic, LLC
General Atlantic is a leading global growth equity firm providing capital and strategic support for growth companies. General Atlantic combines a collaborative global approach, sector-specific expertise, and a deep understanding of growth drivers to build exceptional businesses worldwide. "
target parent: The Vistria Group
target: CareMetx
CareMetx is a leading technology-enabled hub services platform facilitating patient access to specialty medications. CareMetx leverages digital eServices integrated in a cohesive platform to promote efficiency in the healthcare ecosystem and remove barriers for patients and providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/12/2020 via Company Press Release

Pharmalex, acquired Arbour Group

synopsis: The PharmaLex Group, a leading German specialist provider of development consulting and scientific affairs, regulatory affairs, and pharmacovigilance, has acquired Arbour Group, LLC from Keystone Capital, Inc. Arbour is a leading provider of regulatory compliance solutions for the global life sciences industry.
buyer parent: AUCTUS Capital Partners
buyer: Pharmalex
Germany-based PharmaLex is one of the largest providers of specialist services for Development Consulting, Regulatory Affairs, Quality Management & Compliance and Pharmacovigilance, Epidemiology, and Risk Management worldwide. "
target parent: Keystone Capital
target: Arbour Group
Arbour Group is a leading provider of regulatory compliance services for the global life sciences industry. Arbour specializes in the areas of software validation, packaged compliance solutions, and software testing/auditing to ensure client compliance with applicable global regulatory bodies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/24/2019 via GlobeNewswire

NNIT, acquired Halfmann Goetsch Partner AG

synopsis: NNIT, one of Denmark's leading IT service providers and consultancies, announced that it has acquired Halfmann Goetsch Partner AG. Headquartered in Basel, Switzerland, Halfmann Goetsch Partner AG is recognized and referenced as one of the strongest providers of IT compliance and quality management services to primarily pharmaceutical companies.
buyer: NNIT (CPSE:NNIT:$459.19)
NNIT A/S is one of Denmark's leading IT service providers and consultancies. NNIT A/S offers a wide range of IT services and solutions to its customers, primarily in the life sciences sector in Denmark and internationally and to customers in the public, enterprise and finance sectors in Denmark. "
target: Halfmann Goetsch Partner AG
Halfmann Goetsch Partner AG, recognized and referenced as one of the strongest providers of IT compliance and quality management services to primarily pharmaceutical companies, is headquartered in Basel, Switzerland.
price ($mm)
$8.39
rev ($mm)
$9
EBITDA ($mm)
EV / rev
1.3x
EV / EBITDA
closed 2/2/2017 via BNC Analysis

Akka Technologies, acquired CTP System

synopsis: AKKA Technologies announced the acquisition of CTP System in Italy. CTP System is leader in providing Good Manufacturing Practices Services in the field of Life Sciences (Pharmaceutical Engineering & Consulting). CTP System supports its clients with validation and IT Compliance.
buyer: Akka Technologies (ENXTPA:AKA:$1,873.93)
AKKA Technologies is an engineering and technology consulting company that supports its clients in meeting their increasing challenges. They are the European leader in the mobility segment, operating in 20 countries through 21 centers of excellence. "
target: CTP System
Founded in 1990, CTP System is leader in providing Good Manufacturing Practices Services in the field of Life Sciences (Pharmaceutical Engineering & Consulting). CTP System supports its clients with validation and IT Compliance.
price ($mm)
rev ($mm)
$19
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 9/18/2015 via PR Newswire

8KMiles, will acquire NexAge Technologies USA, Inc.

synopsis: 8K Miles Software Services, Ltd., the leading provider of secure Cloud solutions announced that its US subsidiary 8K Miles Software Services, Inc. has entered into a Stock Purchase Agreement with NexAge Technologies USA, Inc., a principal regulatory compliance and technology solutions firm in the US for the Life Science and Pharmaceutical industry.
buyer: 8KMiles (BSE:512161:$56.81)
8K Miles Software Services, Inc. is a US subsidary of 8K Miles Software Services, Ltd. They provide digital technology solutions – SMAC (Social, Mobile, Analytics and Cloud) for seamless connectivity between consumers, SMBs, large enterprises, healthcare providers and pharmaceutical companies. "
target: NexAge Technologies USA, Inc.
NexAge Technologies USA, Inc. provides Regulatory Compliance and proprietary IT solutions for the US Life Sciences Industry. They have 15 years of experience in Computer Systems Validation, Quality Review, Vendor Audits, Data Analysis and Migration, Analytics, Change Management, and Governance.
price ($mm)
$3.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/27/2011 via PR Newswire

Healthcare at Home Ltd, acquired Sciensus Ltd

synopsis: Healthcare at Home Ltd, Europe's leading international provider of home-based healthcare and specialty pharmacy services, is pleased to announce that it has acquired Sciensus Ltd, a provider of health informatics for clients across the NHS and the pharmaceutical industry.
buyer: Healthcare at Home Ltd
Healthcare at Home operates from locations throughout the UK, enabling its services to be provided to patients anywhere in the UK, from a local base. Total staff numbers within the company have risen to just over 1,000, of whom approximately half are highly skilled and experienced clinical staff. "
target: Sciensus Ltd
Sciensus was established in 2003 at the University of Sussex Innovation Centre forging links with local clinical and academic bodies. Sciensus has developed expertise and infrastructure to build market access services with many of the world's leading pharmaceutical companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/14/2021 via Company Press Release

Sikich LLP, will acquire Process Stream

synopsis: Sikich will acquire the assets of Process Stream, a leader in digital transformation services for regulated industries, including life sciences and insurance. The acquisition of Process Stream advances Sikich's efforts to support businesses with end-to-end technology-enabled professional services.
buyer: Sikich LLP
Sikich is a global company specializing in technology-enabled professional services. With more than 1,000 employees, Sikich draws on a diverse portfolio of technology solutions to deliver transformative digital strategies and ranks as one of the largest CPA firms in the United States. "
target: Process Stream
Process Stream is a leader in digital transformation services for regulated industries, including life sciences and insurance. Process Stream specializes in quality management, IT compliance, and insurtech systems implementations and consulting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/7/2008 via PR Newswire

Signalife, Inc., will acquire Heart One Global Research

synopsis: Signalife, Inc. and Heart One Global Research, an Irish-based heart information and clinical information management concern -- with technology used across the world through subsidiaries and affiliates in eight different countries have agreed to merge or consummate a similar business combination making them one company.
buyer: Signalife, Inc. (SGN:$0.00)
Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring. "
target: Heart One Global Research
Heart One Global is the London-based international developer and distributor of information technologies that are clinically focused, mature, stable, robust, comprehensive, flexible, portable, and standards-based electronic health record solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/26/2007 via BusinessWire

McKesson Corporation, acquired Per-Se Technologies, Inc.

synopsis: McKesson Corporation announced that it has successfully completed the previously announced acquisition of Per-Se Technologies, Inc. in an all-cash transaction that closed today.
buyer: McKesson Corporation (MCK:$214,319.00)
McKesson Corporation, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. "
target: Per-Se Technologies, Inc.
Per-Se Technologies, Inc. delivers services and solutions to the healthcare industry through three divisions: Physician Services, e-Health Solutions and Application Software.
price ($mm)
$1,644
rev ($mm)
$541
EBITDA ($mm)
$107
EV / rev
3.0x
EV / EBITDA
15.4x
closed 12/6/2010 via PR Newswire

American CyberSystems Inc., acquired XRoads Consulting

synopsis: American CyberSystems, Inc. (ACS), a global information technology services company, announced the acquisition of XRoads Consulting. The acquisition broadens the ACS footprint technically with added solutions expertise and vertically into the healthcare industry marketplace.
buyer: American CyberSystems Inc.
American CyberSystems, Inc. is a global information technology services company, offering IT consulting and staffing services, systems integration, and business solutions to organizations in a variety of industries. "
target: XRoads Consulting
Originated in 2005, XRoads Consulting is an Atlanta-based IT services company that provides a broad range of information technology specialists to Fortune 500 companies. The company has specialized in providing talent within business intelligence and data warehousing areas of functional expertise.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/2/2007 via PR Newswire

InfoLogix, acquired Healthcare Informatics Associates, Inc.

synopsis: InfoLogix, Inc., a leading technology provider of mobile enterprise solutions for the healthcare and commercial industries, announced today that it has acquired Healthcare Informatics Associates, Inc., a leading management and clinical/financial systems consulting company dedicated to the healthcare industry.
buyer: InfoLogix
As the leading provider of mobile intelligence solutions, InfoLogix uses the industry's most advanced wireless information technology to increase the efficiency, accuracy, and transparency of complex business and clinical processes. "
target: Healthcare Informatics Associates, Inc.
Healthcare Informatics Associates, Inc is a Management and Systems Consulting Company dedicated to the Healthcare Industry. HIA has established an enviable track record of helping clients be significantly more successful in the use of their information systems.
price ($mm)[EV]
$14 [$12]
rev ($mm)
$10
EBITDA ($mm)
$2
EV / rev
1.2x
EV / EBITDA
5.7x
closed 1/9/2020 via BusinessWire

The Clarke Companies, acquired Covex, LLC

synopsis: The Clarke Companies, a leading provider of packaging, automation, validation and vision inspection services to the Life Sciences Industry, has acquired Covex, LLC, the premier global provider of validation, compliance, engineering and IT services for the Pharmaceutical, Life Sciences, and Chemical industries.
buyer: The Clarke Companies
The Clarke Companies is a leading provider of packaging, automation, validation and vision inspection services to the Life Sciences Industry. The Clarke Companies include Clarke Solutions and Acquire Automation. "
target: Covex, LLC
Covex, LLC is the premier global provider of validation and compliance services for the Pharmaceutical, Life Sciences, and Chemical industries. Covex Systems Validation, Regulatory Compliance, Engineering and IT Services offer an end-to-end solution for their clients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/6/2007 via

Arlington Capital Partners, acquired Advanced Health Media

synopsis: Arlington Capital is near a deal to buy a majority stake in Advanced Health Media, a provider of marketing services and software to pharmaceutical companies, people familiar with the matter said.
buyer: Arlington Capital Partners
Arlington Capital Partners is a private equity firm with over $450 million of committed capital. We are focused on management buyout and late stage expansion equity investment opportunities. Our target is middle-market companies with enterprise values typically between $50 million and $500 million. "
target: Advanced Health Media
Advanced Health Media, Inc. ("AHM") is an all-media medical communications and marketing firm. AHM combines industry experience and technological innovation to supply custom marketing solutions and services to the pharmaceutical industry.
price ($mm)
rev ($mm)
$200
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 4/13/2020 via Company Press Release

IntegriChain, Inc., purchased Life Sciences Division from Cumberland Consulting Group, LLC

synopsis: IntegriChain, a leading Life Sciences data and managed services company that helps drive access to life-saving and life-changing medicines, announced that it has acquired Cumberland’s Life Science Division, a leading provider of managed services, advisory services and systems integration for contracts, pricing and revenue management.
buyer parent: Accel-KKR
buyer: IntegriChain, Inc.
IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 220 manufacturers rely on IntegriChain’s analytics, applications to power their market access operations and harness the value of their channel, patient and payer data. "
seller parent: Tailwind Capital Partners
seller: Cumberland Consulting Group, LLC
Cumberland’s Life Science Division is a leading provider of managed services, advisory services and systems integration for contracts, pricing and revenue management. They offer a variety of scalable services for pharmaceutical manufacturers of all sizes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/13/2007 via PR Newswire

Cegedim Group S.A., acquired 3ES

synopsis: Cegedim Strategic Data, leading provider of Pharmaceutical Market Research has completed its acquisition of 3ES, a CRO member of the AFCRO, specializing in Clinical Studies and post-AMM studies, notably through online tools.
buyer: Cegedim Group S.A. (ENXTPA:CGM:$592.02)
Established as the world's leading CRM provider for the life sciences industry with its Cegedim Dendrite business unit, CEGEDIM provides the world's largest pharmaceutical companies with vital support for successful Customer Relationship Management (CRM). "
target: 3ES
3ES provides multidisciplinary expertise in the medical research field. 3ES has developed their in-house software for managing online studies via Internet, and has received the ANVAR label for "innovating business".
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2015 via BusinessWire

Certara, acquired XenologiQ

synopsis: Certara, the global biosimulation technology-enabled drug development company, acquired XenologiQ, a UK-based quantitative systems pharmacology consultancy. XenologiQ's mission is to productively implement state-of-the-art modeling and simulation in medical and life sciences research.
buyer parent: Arsenal Capital Partners
buyer: Certara (:$261.77)
Certara is a global biosimulation technology-enabled drug development company. Certara’s solutions enable superior drug development and regulatory decision-making through biosimulation, thus increasing R&D productivity and commercial value. "
target: XenologiQ
XenologiQ is a UK-based consulting company. Its mission is to productively implement state-of-the-art modeling and simulation in medical and life sciences research. Its value proposition is to achieve this via the optimal integration of experience, technical excellence and global talent.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/25/2005 via PR Newswire

Affiliated Computer Services, Inc., acquired Superior Consultant Holdings Corporation

synopsis: Affiliated Computer Services, Inc., a premier provider of business process and information technology outsourcing solutions, announced today the successful completion of the cash tender offer by its wholly owned subsidiary, ACS Merger Corp., for all of the shares of common stock of Superior Consultant Holdings Corporation.
buyer: Affiliated Computer Services, Inc.
Affiliated Computer Services, Inc., a global FORTUNE 500 company with 74,000 people supporting client operations reaching 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. "
target: Superior Consultant Holdings Corporation
Continually at the forefront of health care information technology innovation since our establishment in 1984, Superior Consultant Company provides the health care industry a full array of IT consulting, IT outsourcing, and management consulting solutions. Our clients include hospitals and health s
price ($mm)
$95
rev ($mm)
$111
EBITDA ($mm)
$8
EV / rev
0.9x
EV / EBITDA
11.7x
announced 11/20/2008 via PR Newswire

AETEA Information Technology, Inc., will acquire ecipient Technologies, LLC

synopsis: AETEA Information Technology, Inc. announced it has signed a definitive agreement to acquire ecipient Technologies. ecipient provides information technology consulting services in the areas of enterprise application development, systems integration, enterprise reporting and analytics to leading commercial organizations.
buyer: AETEA Information Technology, Inc.
AETEA is a recognized market leader with over 25 years of experience providing professional IT consulting services. AETEA specializes in assisting its customers to solve business problems through technology. "
target: ecipient Technologies, LLC
ecipient offers extensive domain expertise in the pharmaceutical manufacturing space, providing customized applications for clinical, regulatory, research and development needs as well as portfolio management.
price ($mm)
$28
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/6/2017 via Market Wire

VistaVu Solutions, acquired BPBD, LLC

synopsis: VistaVu Solutions, one of the top SAP-certified partners in North America, is pleased to announce that they have acquired BPBD, LLC, a leading system provider and integrator for SAP Business ByDesign, which offers a smarter way to customize client's software implementations.
buyer: VistaVu Solutions
VistaVu Solutions, one of the top SAP-certified partners in North America, is a focused, rapidly-growing and progressive provider of business management solutions for the industries of Industrial Field Services, Industrial Manufacturing & Components, Aerospace & Defense, and Life Sciences. "
target: BPBD, LLC
BPBD is a leading system provider and integrator for SAP Business ByDesign, which offers a smarter way to customize client's software implementations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/21/2015 via PR Newswire

BioClinica, Inc., acquired Synowledge

synopsis: BioClinica, Inc., a specialty clinical trials services and technology provider, announced that it has acquired Synowledge to expand into the drug safety and regulatory business process outsourcing market. Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies.
buyer parent: JLL Partners
buyer: BioClinica, Inc.
BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. "
target: Synowledge
Synowledge is a specialized drug safety, regulatory affairs and IT services provider that assists and enables small, medium and large life sciences organizations to satisfy their global regulatory requirements.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2017 via PR Web

BioClinica, Inc., acquired MDDX

synopsis: Bioclinica, a specialty clinical trials services and technology provider, has acquired MDDX, a developer of tools that have been used by researchers in dozens of global research trials. MDDX has created the most advanced cloud research image management platform that provides a private, searchable online image repository with a 20-year lifespan.
buyer parent: Cinven
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target: MDDX
MDDX has developed nearly a dozen tools that have been used by thousands of researchers in dozens of global research trials. The company has created the most advanced cloud research image management platform that provides a private, searchable online image repository with a 20-year lifespan.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2016 via PR Newswire

BioClinica, Inc., acquired Clinverse, Inc.

synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target: Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/21/2015 via PR Newswire

BioClinica, Inc., acquired Synowledge

synopsis: BioClinica, Inc., a specialty clinical trials services and technology provider, announced that it has acquired Synowledge to expand into the drug safety and regulatory business process outsourcing market. Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies.
buyer parent: JLL Partners
buyer: BioClinica, Inc.
BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. "
target: Synowledge
Synowledge is a specialized drug safety, regulatory affairs and IT services provider that assists and enables small, medium and large life sciences organizations to satisfy their global regulatory requirements.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2014 via PR Newswire

BioClinica, Inc., acquired Blueprint Clinical

synopsis: BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
buyer parent: JLL Partners
buyer: BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated clinical trial management technologies including eClinical solutions for clinical trial supply management, forecasting and optimization, electronic data capture, randomization, and clinical trial management. "
target: Blueprint Clinical
Blueprint Clinical, Inc. creates Software-as-a-Service tools that help improve monitoring of clinical trials. Their first product, Blueprint Clinical Compass™, ultimately allows risk based monitoring implementation thereby improving quality and efficiency of clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/11/2013 via BusinessWire

JLL Partners, will acquire BioClinica, Inc.

synopsis: BioClinica®, Inc., a leading global provider of clinical trial management solutions and JLL Partners, Inc. announced that BC Acquisition Corp., which is a wholly-owned subsidiary of BioCore Holdings, Inc., each of which is an affiliate of JLL, has commenced a tender offer for all outstanding shares of BioClinica.
buyer: JLL Partners
JLL Partners is a leading New York-based private equity investment firm with approximately $4 billion of capital under management. JLL Partners’ investment philosophy is to partner with outstanding management teams and invest in companies that they can continue to grow into market leaders. "
target: BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica solutions maximize efficiency and manageability throughout all phases of the clinical trial process.
price ($mm)[EV]
$114 [$105]
rev ($mm)
$79
EBITDA ($mm)
$10
EV / rev
1.4x
EV / EBITDA
10.5x
closed 3/26/2010 via BusinessWire

BioClinica, Inc., acquired TranSenda International, LLC.

synopsis: BioClinica™, Inc., a global provider of clinical trial management services, announced its acquisition of substantially all of the assets of TranSenda International, LLC (“TranSenda”). TranSenda is a provider of clinical trial management software (CTMS) solutions and is a Microsoft Gold Certified Partner.
buyer: BioClinica, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
target: TranSenda International, LLC.
TranSenda is transforming the clinical trial environment by delivering solutions that address the underserved need to improve the "business-process" side of clinical trial operations. TranSenda provides modular software solutions for small to mid-sized companies engaged in clinical trials.
price ($mm)
$2.10
rev ($mm)
$1
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 9/1/2009 via BusinessWire

BioClinica, Inc., acquired CardioNow, Inc.

synopsis: BioClinica, Inc., a global provider of clinical trial services, announced that it has acquired the CardioNow unit of Agfa HealthCare. With this addition, BioClinica now offers streamlined electronic transport solutions to facilitate the blinding, sharing, tracking and archiving of medical images for multi-center clinical trials.
buyer: BioClinica, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
target parent: Agfa Corp.
target: CardioNow, Inc.
CardioNow is an Image Management Service (IMS) that stores cardiac images, and transmits these images to cardiologists over the Internet as needed. The company also provides management consulting services for cardiologists.
price ($mm)
$1.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2008 via BusinessWire

Bio-Imaging Technologies, Inc., acquired Phoenix Data Systems Inc.

synopsis: Bio-Imaging Technologies, Inc. it has acquired privately held Phoenix Data Systems, Inc., a leading global clinical data services provider of electronic data capture services and a comprehensive array of broadly interoperable eClinical data solutions to the pharmaceutical and biotechnology industries.
buyer: Bio-Imaging Technologies, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
target: Phoenix Data Systems Inc.
Phoenix Data Systems delivers Full Service EDC, a unique combination of electronic data capture, interactive voice response, reporting, and data management services that give clinical data managers improved control to run well-managed studies.
price ($mm)[EV]
$19 [$18]
rev ($mm)
$12
EBITDA ($mm)
$1
EV / rev
1.8x
EV / EBITDA
15.4x
closed 7/9/2007 via BusinessWire

CapMed Corporation, acquired Juke Systems, Inc.

synopsis: CapMed, a Division of Bio-Imaging Technologies, Inc. a leader in PHR solutions, has announced the acquisition of the patent-pending ICE First™ technology of Juke Systems, Inc. ICE First™ is an innovative mobile phone and web-based software tool for the storage and display of emergency medical information.
buyer parent: Bio-Imaging Technologies, Inc.
buyer: CapMed Corporation
CapMed, a division of Bio-Imaging Technologies, Inc., is the leading provider of interactive personal health management solutions for the healthcare and pharmaceutical industries. "
target: Juke Systems, Inc.
Juke Systems, Inc., a dynamic new technology company, is focused on developing new and important ways to make mobile phones an even more significant part of everyday life. It starts with thinking about mobile phones in a whole new way, beyond just as a communication device.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/6/2007 via BusinessWire

Bio-Imaging Technologies, Inc., acquired Theralys SA

synopsis: Bio-Imaging Technologies, Inc. announced the acquisition of Theralys SA. Theralys’ proprietary image processing software enables the introduction of quantitative imaging markers in the design of clinical trials for Neurovascular and CNS disorders.
buyer: Bio-Imaging Technologies, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
target: Theralys SA
Theralys, founded in 2001 and based in Lyon, France, operates an imaging core lab providing centralized blinded read services and image analysis. Their proprietary and validated software for clinical trials includes applications which enable the automated quantitation of various imaging parameters.
price ($mm)
$4.26
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/30/2021 via BNC Analysis

CSAM Health AS, acquired MedSciNet

synopsis: CSAM Health Group AS, the leading provider of niche eHealth solutions in the Nordics, announced that they have acquired MedSciNet AB, a provider of benchmark eHealth solutions within clinical research.
buyer: CSAM Health AS (OB:CSAM:$30.36)
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
target: MedSciNet
MedSciNet is a Stockholm based company specialising in design and development of web applications and on-line database systems for clinical trials and studies, quality registries, medical bio-banks, and other solutions within the medical field.
price ($mm)
$2.88
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
announced 5/27/2021 via PR Newswire

Thoma Bravo, LLC, will acquire Greenphire, Inc

synopsis: Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.
buyer: Thoma Bravo, LLC
Thoma Bravo is a leading private equity firm focused on the software and technology-enabled services sectors. Thoma Bravo partners with a company’s management team to implement operating best practices, invest in growth initiatives and make acquisitions intended to accelerate revenue and earnings. "
target parent: The Riverside Company
target: Greenphire, Inc
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2021 via GlobeNewswire

Scarritt Group Inc., acquired TrialTech Medical Inc.

synopsis: Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, has acquired TrialTech Medical Inc, a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials.
buyer: Scarritt Group Inc.
Scarritt Group is a technology-enabled, full service meeting planning and logistics company specializing in delivering clinical trial meetings worldwide. "
target: TrialTech Medical Inc.
TrialTech Medical is a software and services company supporting the pharmaceutical, biotechnology and medical device industries. They work in coordination with their clients' medical and clinical operations teams to optimize the process of clinical trial planning, recruitment and enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/19/2020 via Company Press Release

Capvis Equity, will acquire BSI Business Systems Integration

synopsis: Capvis AG, a leading private equity firm in Switzerland, will acquire a majority stake in BSI Business Systems Integration AG, a Swiss customer relationship management (CRM) software solution provider. BSI offers an omnichannel CRM and marketing automation platform that helps businesses to better support their customers.
buyer: Capvis Equity
Capvis is the leading private equity firm in Switzerland and a top player in German-speaking Europe. Capvis invests in well-positioned midsize firms with headquarters in Switzerland, Germany or Austria, typically as part of succession solutions and corporate spin-offs. "
target: BSI Business Systems Integration
Business Systems Integration (BSI) is a Swiss customer relationship management (CRM) software solution provider. BSI offers an omnichannel CRM and marketing automation platform that helps businesses to better support their customers. BIS also offers a clinical trial management software solution.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$14,891.70)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,323.17)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 4/10/2019 via BNC Analysis

TriNetX, acquired Custodix N.V.

synopsis: TriNetX has acquired Custodix, a Belgian-based provider of clinical trial patient recruitment solutions. TriNetX is a global health research network that has revolutionised clinical research. Custodix is a provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance.
buyer: TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. "
target: Custodix N.V.
Custodix is a Belgian provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance with European and US data protection legislation and security best practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/17/2018 via Company Press Release

Oracle Corporation, will acquire GoBalto

synopsis: Oracle announced that it has entered into an agreement to acquire goBalto, which delivers leading cloud solutions to accelerate clinical trials by streamlining and automating the selection and set up of the best performing clinical research sites to conduct trials.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle is a computer technology corporation developing and marketing computer hardware systems and enterprise software products. By eliminating complexity and simplifying IT, Oracle enables its customers to accelerate innovation and create added value for their customers. "
target: GoBalto
goBalto, Inc. is an award winning, venture backed group of industry veterans that creates simple, focused software for the global drug trial industry. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/18/2018 via PR Newswire

Genstar Capital LLC, acquired CRF Health

synopsis: Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry. CRF Health's eSource solutions improve trial engagement by making the patient the center of the clinical trial process.
buyer: Genstar Capital LLC
Genstar Capital is a leading private equity firm that has been actively investing in high quality companies for more than 25 years. Based in San Francisco, Genstar works in partnership with its management teams to transform its portfolio companies into industry-leading businesses. "
target parent: Vitruvian Partners LLP
target: CRF Health
CRF Health is the leading provider of patient-centered eSource technology solutions for the life sciences industry. CRF Health's TrialMax® platform consistently demonstrates the industry's highest data accuracy, patient and site compliance, and patient retention.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/21/2018 via BusinessWire

Anju Software, acquired Sylogent

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2017 via PR Newswire

Bracket Global, acquired mProve Health

synopsis: Bracket, a leading clinical trial technology and specialty services provider, announced the strategic acquisition of mProve Health Inc., a leading provider of mobile technologies for life science companies. mProve Health offers regulatory compliant mobile solutions for patient recruitment and electronic clinical outcome assessments.
buyer parent: Genstar Capital LLC
buyer: Bracket Global
Bracket is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. "
target: mProve Health
mProve Health is a leading provider of mobile technologies for life science companies, helping them connect better with patients. The company offers industry-grade, regulatory compliant mobile solutions for patient recruitment, patient engagement, and electronic clinical outcome assessments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

PRA Health Sciences, acquired Parallel 6

synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent: HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/31/2017 via BusinessWire

Anju Software, acquired ClinPlus

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired the assets of ClinPlus, a division of DZS Software Solutions, Inc. ClinPlus has a full suite of products used for the performance of clinical trials including EDC, IWRS, CTMS, eTMF, Data Management, Coding and SAS Reporting.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions with outstanding customer support. Anju was founded by a group of operating and investment professionals with deep software domain expertise. "
target parent: DZS Software Solutions, Inc.
target: ClinPlus
ClinPlus, a division of DZS Software Solutions, Inc., has a full suite of products used for the performance of clinical trials including EDC, IWRS, CTMS, eTMF, Data Management, Coding and SAS Reporting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/28/2017 via PR Newswire

Genstar Capital LLC, acquired Bracket Global

synopsis: Genstar Capital, a middle-market private equity firm focused on investments in targeted segments of the healthcare, financial services, software, and industrial technology industries, announced that it has acquired Bracket, a leading scientifically-driven clinical trial technology and specialty services provider, from Parthenon Capital Partners.
buyer: Genstar Capital LLC
Genstar Capital is a San Francisco-based private equity firm that invests in leading middle-market companies. For over 20 years, they have utilized their deep industry knowledge and extensive executive networks to create value at their companies. "
target parent: Parthenon Capital Partners
target: Bracket Global
Bracket is a specialty services provider dedicated to helping pharmaceutical sponsors and contract research organizations (CROs) achieve greater certainty and accurate outcomes in their clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/16/2016 via BNC Analysis

DrugDev, acquired SecureConsent

synopsis: DrugDev has acquired SecureConsent, a developer of mobile e-consent software. SecureConsent replaces the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
buyer: DrugDev
DrugDev streamlines engagement among sponsors, CROs and doctors to advance the common goal of doing more trials. Through the creation of global, standardized processes DrugDev is consistently and efficiently transforming the way drug developers identify, engage and pay investigators. "
target: SecureConsent
The software products developed by Secure Consent replace the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/18/2016 via BNC Analysis

PRA Health Sciences, acquired Nextrials, Inc.

synopsis: PRA Health Sciences acquired all of the outstanding shares of Nextrials, Inc., a developer of web-based software which integrates electronic health records with clinical trials. Nextrials is an innovative, award-winning, leader in web-based software solutions for the clinical research industry.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
At PRA Health Sciences, providing innovative solutions for their clients is what they do. They strive to move drug discovery forward, to help them develop life-saving and life- improving drugs. "
target: Nextrials, Inc.
Nextrials is an innovative, award-winning, leader in web-based software solutions for the clinical research industry. Prism®, the Company’s clinical trial management software, brings together sophisticated trial management and electronic data capture (“EDC”) in a single package.
price ($mm)
$4.70
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2016 via PR Newswire

BioClinica, Inc., acquired Clinverse, Inc.

synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target: Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Synowledge


read more

Synowledge

CareMetx

Arbour Group

Halfmann Goetsch Partner AG

CTP System

NexAge Technologies USA, Inc.

Sciensus Ltd

Process Stream

Heart One Global Research

Per-Se Technologies, Inc.

XRoads Consulting

Healthcare Informatics Associates, Inc.

Covex, LLC

Advanced Health Media

Cumberland Consulting Group, LLC

3ES

XenologiQ

Superior Consultant Holdings Corporation

ecipient Technologies, LLC

BPBD, LLC

read more

Synowledge

read more

MDDX

Clinverse, Inc.

Synowledge

Blueprint Clinical

BioClinica, Inc.

TranSenda International, LLC.

CardioNow, Inc.

Phoenix Data Systems Inc.

Juke Systems, Inc.

Theralys SA

read more

MedSciNet

Greenphire, Inc

TrialTech Medical Inc.

BSI Business Systems Integration

Viedoc

Clinical Trial Connect, LLC

THREAD Research

OmniComm Systems, Inc.

Medidata

Custodix N.V.

GoBalto

CRF Health

Sylogent

mProve Health

Parallel 6

ClinPlus

Bracket Global

SecureConsent

Nextrials, Inc.

Clinverse, Inc.

Geography
Matching Companies
Ticker: CPSE:NNIT
 
 
 
 
 
 
 
 
NNIT
NNIT
NNIT A/S is one of Denmark's leading IT service providers and consultancies. NNIT A/S offers a wide range of IT services and solutions to its customers, primarily in the life sciences sector in Denmark and internationally and to customers in the public, enterprise and finance sectors in Denmark.
year
2020
rev ($mm)
$459.19
EBITDA ($mm)
$51.30
EBIT ($mm)
$30.43
Net Income ($mm)
$18.48
Employees
3035
  • drill down
  • watch
Ticker: OTCPK:ITOX
 
 
 
 
 
 
 
 
IIOT-OXYS, Inc.
IIOT-OXYS, Inc.
IIOT-OXYS, Inc. is a technology company at the intersection of IIoT, AI & Machine Learning, Edge Computing and Manufacturing Operations. They provide actionable mission critical insights for the Medical/Pharmaceutical, Manufacturing, Agriculture, Defense, and Structural Health, and other industries.
year
2019
rev ($mm)
$0.23
EBITDA ($mm)
EBIT ($mm)
($1.78)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: OTCPK:HLIX
 
 
 
 
 
 
 
 
Helix TCS
Helix TCS
Helix TCS is the premier provider of integrated Operating Environments for the Legal Cannabis Industry, allowing their clients to manage risk and focus on their core business. They accomplish this through a proprietary software suite and partnership platform.
year
2018
rev ($mm)
$4.47
EBITDA ($mm)
($3.88)
EBIT ($mm)
($4.50)
Net Income ($mm)
Employees
98
  • drill down
  • watch
Ticker: BIT:GPI
 
 
 
 
 
 
 
 
GPI S.p.A.
GPI S.p.A.
GPI SpA is the leading technology partner in the Health and Social market. The Group's offer combines IT expertise, consulting and design competences that enable to operate in several business areas: Information Systems, Healthcare, Logistics and Robotization, ICT Services and Monetary Services.
year
2019
rev ($mm)
$269.49
EBITDA ($mm)
$32.35
EBIT ($mm)
$16.87
Net Income ($mm)
$10.47
Employees
3904
  • drill down
  • watch
Ticker: BIT:TBS
 
 
 
 
 
 
 
 
TBS Group
TBS Group designs and manages outsourced clinical engineering and ICT services in order to make the use and management of biomedical and ICT technologies safer and more effective in the health and social facilities, both public and private.
year
2016
rev ($mm)
$248.66
EBITDA ($mm)
$20.26
EBIT ($mm)
$8.78
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: ENXTLS:GLINT
 
 
 
 
 
 
 
 
Glintt
Glintt
Glintt is a leading consulting and technological services company based in Portugal. Glintt develops products for hospitals, clinics and pharmacies. They support their clients in their digital transformation and offers software solutions that helps them to run their business more efficiently.
year
2021
rev ($mm)
$108.88
EBITDA ($mm)
$8.80
EBIT ($mm)
$7.81
Net Income ($mm)
$1.63
Employees
1084
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.90
EBITDA ($mm)
$6.31
EBIT ($mm)
$5.20
Net Income ($mm)
$3.13
Employees
304
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: SLP
 
 
 
 
 
 
 
 
Simulations Plus, Inc.
Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software that is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide.
year
2019
rev ($mm)
$35.84
EBITDA ($mm)
$12.38
EBIT ($mm)
$11.28
Net Income ($mm)
$9.11
Employees
109
  • drill down
  • watch
Ticker: POAI
 
 
 
 
 
 
 
 
Predictive Oncology Inc.
Predictive Oncology Inc.
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery. Predictive Oncology operates through five segments which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe.
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($13.26)
EBIT ($mm)
($13.71)
Net Income ($mm)
Employees
24
  • drill down
  • watch
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2021
rev ($mm)
$914.37
EBITDA ($mm)
$99.36
EBIT ($mm)
$57.86
Net Income ($mm)
$35.01
Employees
2970
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: MRCY
 
 
 
 
 
 
 
 
Mercury Computer Systems, Inc.
Mercury Computer Systems, Inc.
Mercury Computer Systems is the leading supplier of high-performance digital signal and image processing systems. These embedded computer systems transform streams of sensor data to visual information in real time for analysis and interpretation.
year
2011
rev ($mm)
$228.71
EBITDA ($mm)
$33.90
EBIT ($mm)
$25.55
Net Income ($mm)
$18.44
Employees
602
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch